Follicular lymphoma: open trials in Australia

18 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT07249905
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Trial Treatment · Phase 1/2 · ModeX Therapeutics, An OPKO Health Company
Linear Clinical Research, Nedlands · Epworth Healthcare, Richmond
Registry updated 2026-11-06
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
The Alfred Hospital, Melbourne, VIC · Linear Clinical Research, Nedlands
Registry updated 2026-11-04
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Royal Adelaide Hospital, Adelaide · Royal Hobart Hospital, Hobart · Linear Clinical Research, Perth · Westmead Hospital, Westmead
Registry updated 2026-11-03
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Monash Health, Clayton · Austin Health, Melbourne · Linear Clinical Research, Nedlands · Gold Coast Hospital, Southport
Registry updated 2026-11-02
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Royal Adelaide Hospital (Site 0205), Adelaide · Box Hill Hospital (Site 0202), Box Hill · Townsville University Hospital (Site 0204), Townsville
Registry updated 2026-10-29
NCT07634471
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Box Hill Hospital (Site 0201), Box Hill
Registry updated 2026-10-26
NCT06549595
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Trial Treatment · Phase 3 · AstraZeneca
Clayton · Darlinghurst · Garran · Heidelberg · Macquarie University · Nedlands
Registry updated 2026-10-21
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Heidelberg · Kogarah · Macquarie University · Nedlands
Registry updated 2026-10-14
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
Epworth Hospital, East Melbourne
Registry updated 2026-10-09
NCT06149286
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Pindara Private Hospital, Benowa · Epworth Freemasons, East Melbourne · Royal Hobart Hospital, Hobart · Liverpool Hospital, Liverpool · Calvary Mater Newcastle, Waratah
Registry updated 2026-10-07
NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
ICON Cancer Centre Wesley, Auchenflower · Flinders Medical Centre, Bedford Park · Monash Health, Clayton · Epworth Freemasons, East Melbourne · Ingham Institute, Liverpool · St Vincents Hospital Melbourne, Melbourne · Alfred Hospital and Monash University, Melbourne
Registry updated 2026-10-06
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Concord Repatriation General Hospital, Concord · St Vincents Hospital Melbourne, Fitzroy · Austin Health, Heidelberg · Peter MacCallum Cancer Centre, Melbourne · The Alfred Hospital, Melbourne · Linear Clinical Research, Nedlands · Calvary Mater Newcastle, Waratah · Perth Blood Institute, West Perth · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-05
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Melbourne · Nedlands
Registry updated 2026-09-30
NCT05826535
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Trial Treatment · Phase 1/2 · Lyell Immunopharma, Inc.
The Alfred Hospital, Melbourne · Sir Charles Gairdner Hospital, Nedlands · Royal Perth Hospital, Perth
Registry updated 2026-08-25
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Trial Treatment · Phase 3 · Celgene
Adelaide · Heidelberg · Hobart · Cabrini Hospital - Malvern, Malvern · Perth · Perth · Westmead Hospital, Westmead
Registry updated 2026-05-20
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Research · AbbVie
Nepean Cancer Centre, Nepean Hospital /ID# 277782, Kingswood · Cabrini Hospital Malvern /ID# 277780, Malvern · Calvary Mater Newcastle /ID# 277783, Waratah
Registry updated 2026-02-17
NCT06022029
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Trial Treatment · Phase 1 · OncoNano Medicine, Inc.
Southern Oncology Clinical Research Unit, Bedford Park · University of the Sunshine Coast Clinical Trials, Buderim · St Vincent's Hospital, Darlinghurst · Tasman Oncology Research, Southport · St. John of God Subiaco Hospital, Subiaco · Cancer Care Wollongong, Wollongong · Princess Alexandra Hospital | Metro South Health, Woolloongabba
Registry updated 2025-12-24
NCT05643742
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1/2 · CRISPR Therapeutics AG
Royal Prince Alfred, Camperdown · Alfred Health, Melbourne · Sir Charles Gairdner Hospital, Nedlands
Registry updated 2025-11-14

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error